Venetoclax-based regimens in combination with trametinib for RAS-mutated relapsed or refractory myeloid malignancies

被引：3
|
作者：
Kevlicius, Lukas [1 ,2 ]
Cepulyte, Ruta [1 ]
Vasilevska, Dominika [2 ]
Griskevicius, Laimonas [1 ,2 ]
Zucenka, Andrius [1 ,2 ]
机构：
[1] Vilnius Univ Hosp Santaros Klinikos, Hematol Oncol & Transfus Med Ctr, Vilnius, Lithuania
[2] Vilnius Univ, Fac Med, Inst Clin Med, Vilnius, Lithuania
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / 06期
关键词：
D O I：
10.1038/s41409-022-01679-6
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1034 / 1037
页数：4
相关论文
共 50 条
  • [31] Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies
    DiNardo, Courtney D.
    Rausch, Caitlin R.
    Benton, Christopher
    Kadia, Tapan
    Jain, Nitin
    Pemmaraju, Naveen
    Daver, Naval
    Covert, Wendy
    Marx, Kayleigh R.
    Mace, Morgan
    Jabbour, Elias
    Cortes, Jorge
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Bhalla, Kapil N.
    Kantarjian, Hagop
    Konopleva, Marina
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (03) : 401 - 407
  • [32] Real-World Experience with Venetoclax-Based Regimens for the Treatment of Acute Myeloid Leukemia
    Ceparano, Giusy
    Sciume, Mariarita
    Fabris, Sonia
    Barozzi, Enrico
    Rampi, Nicolo
    De Roberto, Pasquale
    Baldini, Luca
    Fracchiolla, Nicola Stefano
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S298 - S298
  • [33] Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies
    Griffioen, Mila S.
    de Leeuw, David C.
    Janssen, Jeroen J. W. M.
    Smit, Linda
    CANCERS, 2022, 14 (14)
  • [34] Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia
    Sciume, Mariarita
    Bosi, Alessandro
    Canzi, Marta
    Ceparano, Giusy
    Serpenti, Fabio
    De Roberto, Pasquale
    Fabris, Sonia
    Tagliaferri, Elena
    Cavallaro, Francesca
    Onida, Francesco
    Fracchiolla, Nicola Stefano
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [35] Optimal therapeutic strategies in relapsed/refractory AML with prior exposure to venetoclax-based therapy
    Bawek, Sawyer
    Burwinkel, Matthew
    Patel, Prutha
    Wang, Katy
    Attwood, Kristopher
    Cronin, Tara
    Fos, Melissa
    Green, Steven
    Sung, Pamela J.
    Thompson, James E.
    Griffiths, Elizabeth A.
    Wang, Eunice S.
    Przespolewski, Amanda C.
    LEUKEMIA RESEARCH, 2025, 150
  • [36] Chidamide in Combination With DCAG With or Without Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia
    Liu, Qingyang
    Zhang, Xiawei
    Lv, Lei
    Xu, Linming
    Jing, Yu
    Gao, Wenjing
    Wang, Lili
    Dou, Liping
    CANCER MEDICINE, 2025, 14 (05):
  • [37] Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies
    Borthakur, Gautam
    Popplewell, Leslie
    Boyiadzis, Michael
    Foran, James
    Platzbecker, Uwe
    Vey, Norbert
    Walter, Roland B.
    Olin, Rebecca
    Raza, Azra
    Giagounidis, Aristoteles
    Al-Kali, Aref
    Jabbour, Elias
    Kadia, Tapan
    Garcia-Manero, Guillermo
    Bauman, John W.
    Wu, Yuehui
    Liu, Yuan
    Schramek, Dan
    Cox, Donna S.
    Wissel, Paul
    Kantarjian, Hagop
    CANCER, 2016, 122 (12) : 1871 - 1879
  • [38] Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
    Aldoss, Ibrahim
    Yang, Dongyun
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Al Malki, Monzr M.
    Mei, Matthew
    Salhotra, Amandeep
    Khaled, Samer
    Nakamura, Ryotaro
    Snyder, David
    O'Donnell, Margaret
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    HAEMATOLOGICA, 2018, 103 (09) : E404 - E407
  • [39] Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia
    Canaani, Jonathan
    Frisch, Avraham
    Pollyea, Daniel A.
    Schwartz, Marc
    Aumann, Shlomzion
    Ganzel, Chezi
    Haran, Arnon
    Even-Zohar, Noa Gross
    Shaulov, Adir
    Vainstein, Vladimir
    Moshe, Yakir
    Ofran, Yishai
    Wolach, Ofir
    Nachmias, Boaz
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (03) : 365 - 372
  • [40] A successful case of venetoclax-based therapy in relapsed/refractory secondary plasma cell leukemia
    Kupsh, Allison
    Arnall, Justin
    Voorhees, Peter
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (05) : 1274 - 1278
12345